Mathias Baumert 1 , Muammar M Kabir , Khidir Dalouk , Charles A Henrikson , Larisa G Tereshchenko . Show Affiliations »
Abstract
BACKGROUND: In heart failure patients with implantable cardioverter defibrillator (ICD) the risk of death from causes other than tachyarrhythmia is substantial. Benefit from ICD is determined by two competing risks: appropriate ICD shock or nonarrhythmic death. The goal of the study was to test predictors of competing outcomes. METHODS: Patients with structural heart disease (N = 234, mean age 58.5 ± 15.1; 71% men, 80% whites, 61% ischemic cardiomyopathy) and primary (75%) or secondary prevention ICD underwent a 5-minute baseline near-field electrogram (NF EGM) recording. VV' alternans triplets were quantified as a percentage of three sinus VV' cycles sequences of "short-long-short" or "long-short-long" order. Appropriate ICD shock for fast ventricular tachycardia (FVT, cycle length ≤240 ms)/ventricular fibrillation (VF) and composite nonarrhythmic death (pump failure death or heart transplant) served as competing outcomes. RESULTS: Over a median follow-up of 2.4 years, 26 patients (4.6% per person-year of follow-up) developed FVT/VF with ICD shock, and 35 (6.3% per person-year of follow-up) had nonarrhythmic death. In competing risk analysis, after adjustment for demographics, left ventricular ejection fraction, New York Heart Association class, cardiomyopathy type, use of class I antiarrhythmics, and diabetes, increased percentage of VV' alternans triplets (>69%) was associated with nonarrhythmic death (subhazard ratio [SHR] 2.09; 95% confidence interval [CI] 1.03-4.23; P = 0.041), rather than with FVT/VF (SHR 1.05; 95% CI 0.45-2.46; P = 0.901). Risk of nonarrhythmic death was especially high in diabetics with VV' alternans triplets in the highest quartile (SHR 3.46; 95% CI 1.41-8.50; P = 0.007). CONCLUSION: In ICD patients with structural heart disease sinus VV' alternans triplets on NF EGM is independently associated with nonarrhythmic death, rather than with FVT/VF. ©2015 Wiley Periodicals, Inc.
BACKGROUND: In heart failure patients with implantable cardioverter defibrillator (ICD ) the risk of death from causes other than tachyarrhythmia is substantial. Benefit from ICD is determined by two competing risks: appropriate ICD shock or nonarrhythmic death . The goal of the study was to test predictors of competing outcomes. METHODS: Patients with structural heart disease (N = 234, mean age 58.5 ± 15.1; 71% men , 80% whites, 61% ischemic cardiomyopathy ) and primary (75%) or secondary prevention ICD underwent a 5-minute baseline near-field electrogram (NF EGM) recording. VV' alternans triplets were quantified as a percentage of three sinus VV' cycles sequences of "short-long-short" or "long-short-long" order. Appropriate ICD shock for fast ventricular tachycardia (FVT, cycle length ≤240 ms)/ventricular fibrillation (VF ) and composite nonarrhythmic death (pump failure death or heart transplant) served as competing outcomes. RESULTS: Over a median follow-up of 2.4 years, 26 patients (4.6% per person -year of follow-up) developed FVT/VF with ICD shock , and 35 (6.3% per person -year of follow-up) had nonarrhythmic death . In competing risk analysis, after adjustment for demographics, left ventricular ejection fraction, New York Heart Association class, cardiomyopathy type , use of class I antiarrhythmics, and diabetes , increased percentage of VV' alternans triplets (>69%) was associated with nonarrhythmic death (subhazard ratio [SHR] 2.09; 95% confidence interval [CI] 1.03-4.23; P = 0.041), rather than with FVT/VF (SHR 1.05; 95% CI 0.45-2.46; P = 0.901). Risk of nonarrhythmic death was especially high in diabetics with VV' alternans triplets in the highest quartile (SHR 3.46; 95% CI 1.41-8.50; P = 0.007). CONCLUSION: In ICD patients with structural heart disease sinus VV ' alternans triplets on NF EGM is independently associated with nonarrhythmic death , rather than with FVT/VF . ©2015 Wiley Periodicals, Inc.
Entities: Disease
Gene
Species
Keywords:
competing risk; implantable cardioverter defibrillator; mortality; ventricular arrhythmia
Mesh: See more »
Year: 2015
PMID: 25752990 PMCID: PMC4414906 DOI: 10.1111/pace.12594
Source DB: PubMed Journal: Pacing Clin Electrophysiol ISSN: 0147-8389 Impact factor: 1.976